vTv Therapeutics

    [td_text_with_title custom_title=”Company description”]vTv Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. Our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.

    We have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer.[/td_text_with_title]

    [td_text_with_title custom_title=”Latest post”]

    Alzheimer’s biotech vTv Therapeutics files for a $173 million IPO

    vTv Therapeutics, a biotech developing treatments for Alzheimer’s and type 2 diabetes, filed on Monday with the SEC to raise up to $173 million in an initial public offering. The High Point, NC-based company, which was founded in 1998 and booked $2 million in sales for the 12 months ended March 31, 2015, plans to […]